Market Access expertise that transforms innovation into sustainable patient access.
From early market assessment to reimbursement and launch execution, we help pharmaceutical and biotech companies navigate pricing, reimbursement, HTA requirements, payer expectations, and value demonstration. Our tailored Market Access solutions accelerate patient access and support successful product launches.
Strategic and tactical support throughout the pricing and reimbursement process, including international reference pricing monitoring, follow-up and submission of pricing approval documents.
End-to-end support for market access and reimbursement activities, from evidence generation and value communication to dossier preparation, HTA submissions, and payer engagement.
Providing expert advice and support on risk-sharing agreements and contractual arrangements for conditional reimbursement.
Preparing clawback calculations. Annual, monthly and quarterly clawback payments. Negotiations with payers.
We help pharmaceutical, biotech and healthcare companies generate evidence to demonstrate product value, support reimbursement and optimise market access throughout the product lifecycle.
Experienced specialists across pricing, reimbursement and clawback.
Flexible support tailored to partner needs and objectives
Deep expertise in complex Market Access processes
Efficient delivery aligned with existing partner processes
Strategic and operational support across the Market Access journey
Driving successful reimbursement outcomes for innovative medicines and transformative therapies through extensive market access expertise across multiple therapeutic areas.
With extensive track of records in successfully serving partners across pharmaceutical industry, we are committed to bridging the healthcare gap across Europe.